Search Results
Aug 24, 2026, 03:01 ET ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
Sustained-Release Formulation… Building a Differentiated CNS PlatformIn particular, ImmunoForge has fused its proprietary long-acting technology, ELP, with the LMT platform to implement BBB penetration and one-month sustained release in a single structure. This is expected to enable applications in
More news about: ImmunoForge Co., Ltd.
Apr 22, 2026, 02:13 ET ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15'
ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first place at 'Novo Nordisk Partnering Day Korea 2026'SEOUL, South
More news about: ImmunoForge Co., Ltd.
Apr 14, 2026, 09:00 ET Metropolis Expands Aviation and Seamless Parking Services Across Key U.S. Airports with AeroParker Launches, Joby Integration, and More
AeroParker at SLC, DSM, MSY, SDF, and MKE, remote check-in at PHX, curbside concierge at IAH, and seamless parking technology at AEX, ITO, KOA, and ELP, enhancing the traveler journey and unlocking operational efficiencies for airportsLOS ANGELES,
More news about: Metropolis
Mar 26, 2026, 10:11 ET ELP Luxury Vacations Surpasses $700 Million in Assets Under Management, Expands Global Luxury Partnerships
SANTA ROSA BEACH, Fla., March 26, 2026 /PRNewswire/ -- ELP Luxury Vacations (ELP), a premier luxury vacation rental and asset management firm along Florida's Emerald Coast, today announced it has surpassed $700 million
More news about: ELP Luxury Vacations
Mar 25, 2026, 10:00 ET Trusted by 10 Million Users: HBADA Launches the HBADA E3 Series 2026 Edition, Crowning the Ultimate $500-Class Ergonomic Office Chair for U.S. Consumers
https://www.amazon.com/stores/Hbada/page/70DB1E9E-27E7-44C7-8A57-E6AE4840779E?lp_asin=B0GS164CTR&ref_=ast_bln&store_ref=bl_ast_dp_brandlogo_stoOfficial Launch Pricing (MSRP):HBADA
More news about: HBADA
Mar 12, 2026, 05:19 ET 이뮤노포지, 2026 Bio Europe Spring에서 전략적 파트너링 진행
PF1804(임상2상 승인)와 관련하여 임상 진행 상황과 글로벌 기술이전 논의를 위해 파트너링 세션에 집중하여 해외 제약사들과 미팅을 진행할 예정이다.또한, 보유 중인 펩타이드 기반 약물의 반감기를 연장함으로써 주1회에서 월 1회 투여를 가능하게 하는 장기 지속 플랫폼인 ELP Platform에 대한 논의와 더불어, 추가로 개발한 BBB penetrating Shuttle Platform인 LMT15 Platform 기술을 소개함으로써 글로벌 제약사들과의 협력을 적극적으로 추진할 계획이다.LMT15 Platform은 Leptin
More news about: ImmunoForge Co., Ltd.
Mar 12, 2026, 04:58 ET ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
Monthly long-acting ELP (Elastin-Like Polypeptide) platform: Peptide conjugation and Protein fusion possibleLMT15 (Leptin receptor-Mediated Transcytosis) platform: BBB shuttle platform incorporating ELP to make monthly CNS-targeted drugsPF1801
More news about: ImmunoForge Co., Ltd.
Jan 26, 2026, 10:00 ET Ellevation Education Launches Benchmark Assessment to Support English Learners and Educators with Timely Growth Data
Benchmark, a new English language proficiency (ELP) assessment designed to help educators monitor English Learner growth throughout the school year and to drive meaningful language development for English Learners nationwide. Most districts rely on annual ELP assessments that arrive too late to inform
More news about: Curriculum Associates, LLC
Jan 08, 2026, 08:00 ET XED and Harvard Graduate School of Education Launch Six-Month Leadership Program for Education Leaders
Education (HGSE), to offer the Education Leadership Program (ELP): a six-month learning journey designed to strengthen the strategic, instructional, and systems-thinking capabilities of education leaders across
More news about: XED Executive Development Limited
Jan 08, 2026, 08:00 ET XED and Harvard Graduate School of Education Launch Six-Month Leadership Program for Education Leaders
Education (HGSE), to offer the Education Leadership Program (ELP): a six-month learning journey designed to strengthen the strategic, instructional, and systems-thinking capabilities of education leaders across
More news about: XED Executive Development Limited
Jan 08, 2026, 01:42 ET XED and Harvard Graduate School of Education Launch Six-Month Leadership Program for Education Leaders
of Education (HGSE), to offer the Education Leadership Program (ELP): a six-month learning journey designed to strengthen the strategic, instructional, and systems-thinking capabilities of education leaders across
More news about: XED Executive Development Limited
Jan 01, 2026, 01:00 ET ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
Monthly long-acting ELP (Elastin-Like Polypeptide) platform: Peptide conjugation and Protein fusion possibleBBB penetrating ELP (Elastin-Like Polypeptide) platform: BBB shuttle platform fusing ELP to make monthly CNS drugsPF1801
More news about: ImmunoForge
Nov 10, 2025, 08:00 ET Johnson & Johnson lança plataforma VARIPULSE™ no Brasil e avança no tratamento da fibrilação atrial
uma empresa da Johnson & Johnson MedTech. © Johnson & Johnson e suas afiliadas 2025. Todos os direitos reservados. BR_ELP_ALEL_405193 1 When compared to procedures that did not use navigation systems. 2 Based
More news about: Johnson & Johnson MedTech
Nov 04, 2025, 21:22 ET Johnson & Johnson 於 APHRS 與 JPHRS 會議中，透過多項臨床及真實世界研究，展示脈衝場消融科技的最新進展
重要資訊：使用前，請參閱本設備隨附的使用說明，了解適應症、禁忌症、副作用、警告和注意事項。注意：美國法律限制該裝置，經醫生銷售或根據醫生的指示銷售。 © Johnson & Johnson 及其附屬公司 2025 年。M_US_ELP_THER_407762 傳媒聯絡： Carlos Taveras
More news about: Johnson & Johnson MedTech
Nov 03, 2025, 14:56 ET 존슨앤드존슨, APHRS 및 JPHRS에서 다양한 임상시험과 실사용 시험을 통해 거둔 펄스장 절제술의 최근 성과 공개
목적, 금기 사항, 부작용, 경고 및 주의 사항을 확인해야 한다.주의: 미국 법률에 따라 본 의료기기는 의사의 처방이나 지시가 있는 경우에만 판매할 수 있다. © 존슨앤드존슨과 그 계열사 2025. M_US_ELP_THER_407762 미디어 문의 : 카를로스 타베라스(Carlos Taveras)
More news about: Johnson & Johnson MedTech
Nov 03, 2025, 13:35 ET Johnson & Johnson、APHRSおよびJPHRSにおいて複数の臨床およびリアルワールドでの研究を通じ、パルスフィールドアブレーションの最新技術革新を発表
重要情報：本製品を使用する前に、添付の使用説明書を参照し、適応症、禁忌、副作用、警告および注意事項をご確認ください。 注意：米国法により、同製品の販売は医師による、または医師の指示による場合にのみ許可されています。 © Johnson & Johnsonおよびその関連会社（2025年）。 M_US_ELP_THER_407762 メディア関係問い合わせ先Carlos Taveras
More news about: Johnson & Johnson MedTech
Nov 03, 2025, 12:54 ET Johnson & Johnson Pamerkan Kemajuan Pulsed Field Ablation Terbaru Disertai Berbagai Penelitian Dunia Nyata dan Penelitian Klinis Dalam APHRS dan JPHRS
membatasi perangkat ini untuk dijual oleh dokter atau atas perintah dokter. © Johnson & Johnson dan afiliasinya tahun 2025. M_US_ELP_THER_407762 Kontak media: Carlos Taveras
More news about: Johnson & Johnson MedTech
Oct 22, 2025, 13:00 ET Internet2 and Google Unveil Leadership Program to Empower Broader AI Access and Next-Generation Innovation
Internet2 NET+ Google AI Education Leadership Program (ELP), designed to accelerate the responsible adoption of artificial intelligence across the higher education and research community. The program provides
More news about: Internet2
Oct 16, 2025, 08:17 ET PacketWatch Launches Rapid Response Assurance
analysts, a pre-negotiated IR agreement, access to the full suite of CrowdStrike tools in the event of an incident through our Engagement License Provider (ELP) partnership, quarterly threat hunts and reviews, and monthly cyber threat intelligence reports. Pricing for this service is comparable to the cost of
More news about: PacketWatch
Sep 16, 2025, 23:30 ET XIME Launches Bloomberg Xperiential Lab: Joins an Exclusive Group of Top Indian Educational Institutions to have the Facility
one of only 30 select educational institutes in India to be recognized as a Bloomberg Experiential Learning Partner (ELP). This initiative highlights XIME's commitment to nurturing future-ready finance professionals through advanced, real-world learning experiences in partnership
More news about: Xavier Institute of Management & Entrepreneurship (XIME)
Sep 12, 2025, 04:43 ET Kanazawa University research: Thermal trigger
and Arai aimed to design an ELP with a transition temperature of a few degrees above body temperature, so that only mild heating was required for inducing the solution-to-coacervate-droplet transition. This ELP was then fused to CASP8. Above the transition temperature, the ELP-CASP8 complexes formed coacervate
More news about: Kanazawa University